# Monthly Injectable BUP for MA Use Disorder (MURB) Trial

> **NCT05283304** · PHASE2 · TERMINATED · sponsor: **Madhukar H. Trivedi, MD** · enrollment: 18 (actual)

## Conditions studied

- Methamphetamine-dependence

## Interventions

- **DRUG:** Buprenorphine injection (BUP-Inj)
- **OTHER:** Placebo injection

## Key facts

- **NCT ID:** NCT05283304
- **Lead sponsor:** Madhukar H. Trivedi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-24
- **Primary completion:** 2023-10-20
- **Final completion:** 2023-11-19
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Side effects of medication
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05283304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05283304, "Monthly Injectable BUP for MA Use Disorder (MURB) Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05283304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*